首页 | 本学科首页   官方微博 | 高级检索  
     

自体胸水上清培养肿瘤浸润性淋巴细胞生长所需白细胞介素-2的适宜剂量
引用本文:邹征云,刘宝瑞. 自体胸水上清培养肿瘤浸润性淋巴细胞生长所需白细胞介素-2的适宜剂量[J]. 医学研究生学报, 2007, 20(3): 240-242,I0002
作者姓名:邹征云  刘宝瑞
作者单位:1. 南京大学医学院附属鼓楼医院肿瘤科,江苏南京,210008;南京中医药大学,江苏南京,210029
2. 南京大学医学院附属鼓楼医院肿瘤科,江苏南京,210008
基金项目:江苏省南京市医学科技发展计划
摘    要:目的:模拟体内环境,摸索出应用自体胸水上清培养肿瘤浸润性淋巴细胞(TIL)时所需白细胞介素-2(IL-2)的最适剂量。方法:恶性胸水中的TIL经贴壁法分离后,分成A、B、C三组,分别应用含有细胞因子IL-2、CD3单克隆抗体(OKT3)及外源凝集素(PHA)的自体胸水上清进行培养,其中A组IL-2终浓度为6000u/ml;B组IL-2首剂终浓度为6 000u/ml,其后换液时改为1000u/ml;C组IL-2终浓度为1000u/ml,比较不同剂量IL-2培养的TIL增殖速率、培养前后免疫表型变化和对自体肿瘤细胞的杀伤活性。结果:培养的第3、7、14和21 d检测发现,三组TIL均发生明显扩增,其中A、B两组间TIL的生长速度无差异,但均明显快于C组;TIL免疫表型变化和对自体肿瘤细胞杀伤活性经组间比较无显著差异。结论:TIL培养时,首剂IL-2的终浓度6000u/ml有着非常重要的意义,它有助于早期解除TIL的免疫抑制状态,使其在培养的第3 d就发生明显的活化和扩增,为自体TIL体外分离后仅作短期培养即回输胸腔,后续胸腔内注入IL-2,使其进一步生长,发挥杀瘤效应,从而为治疗恶性胸水奠定了理论基础。

关 键 词:恶性胸腔积液  肿瘤浸润性淋巴细胞  白细胞介素-2  肿瘤免疫治疗
文章编号:1008-8199(2007)03-0240-03
收稿时间:2005-10-20
修稿时间:2005-10-202006-02-27

Appropriate dosage of interleukin-2 for tumor infiltrating lymphocyte cultured in self-supernatant of malignant pleura fluid
ZOU Zheng-yun,LIU Bao-rui. Appropriate dosage of interleukin-2 for tumor infiltrating lymphocyte cultured in self-supernatant of malignant pleura fluid[J]. Bulletin of Medical Postgraduate, 2007, 20(3): 240-242,I0002
Authors:ZOU Zheng-yun  LIU Bao-rui
Affiliation:1. Department of Oncology, Gulou Hospital, School of Medicine, Nanjing University, Nanfing 210008, Jiangsu, China ; 2. Nanjing Traditional Chinese Medical University, Nanjing 210029 ,Jiangsu, China
Abstract:Objective:To select an appropriate dosage of IL-2 for tumor infiltrating lymphocyte(TIL).Methods:Isolated by the attachment method we established,TIL was cultivated in self-supernatant of malignant pleura,with three different concentrations of IL-2,such as 6000u per ml,6000u per ml for the first administration followed by 1000u per ml,or 1000u per ml.The expansion,killing activity and phenotype changes of TIL cultured in different cultures were assessed.Results:As cultured in self-supernatant of malignant pleura fluid,the concentrations of IL-2,such as 6000u per ml or 6000u per ml for the first administration followed by 1000u per ml seemed benefit for TIL proliferation.Conclusion:6000u per ml of IL-2 for the first administration was very important.It could help TIL to activate and proliferate early.The study described here offers the possibility for TIL cultured in vitro self-supernatant of malignant pleura fluid in vitro for a short time,and then reinfuse to thorax for further expanding and controlling the malignant pleura effusion in the presence of IL-2,and thereby minimizing the risks of contamination.
Keywords:Malignant pleura fluid   Tumor infiltrating lymphocyte   Interleukin-2   Adoptive immunotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号